MARSHALL & POPP, LLC

Lobbying for BRIDGEBIO PHARMA · Biopharmaceutical manufacturer.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $20,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Pharmacy

Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem